Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$30.9 Mln
26/02/2025 01:33
Feb 26 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX: HY LOSS ATTRIBUTABLE A$30.9 MILLION Further company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million